Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisStem CellsCytarabineHodgkin DiseaseGranulocytesDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationInfectionLymphoma, T-CellSurvival AnalysisADP-ribosyl CyclaseTime FactorsDoxorubicinCyclic ADP-RiboseHistocompatibilityPlatelet CountPOEMS SyndromePrednisoneCarboplatinHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneRecombinant ProteinsVidarabineBlood Cell CountLeukemiaFollow-Up StudiesBone Marrow PurgingAntineoplastic AgentsBlood CellsLymphomaCytomegalovirus InfectionsNAD+ NucleosidaseProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAntigens, CD38Myelodysplastic SyndromesAnemia, AplasticImmunophenotypingBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionBone MarrowLeukocytes, MononuclearT-LymphocytesHematologic DiseasesHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensBlood DonorsCyclosporine